논문KCI 등재
Modulation of PRL-1 in placental MSCs: A novel thera peutic strategy for hepatic fibrosis: Editorial on “Mod ulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the tran sition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis”
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosisGi Jin Kim, Hyeri Park, Jae Yeon Kim, Ja Yun Lim, Ki Seog Lee, Se Ho Kim, Si Hyun Bae, Soo Young Park대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives엄영우, Moon Young Kim, Seong Hee Kang, Soon Koo Baik거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제3호Stem cell exosomes: new hope and future potential for relieving liver fibrosisChong Jin, Hao Jiang, Jinggang Mo, Kunpeng Wang, Lihua Li, Yongjie Liu, Zhiyong Weng대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”Yasuko Iwakiri대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis권상옥, 김문영, 백순구, 장윤옥, 전백규대한간학회 · Clinical and Molecular Hepatology2015 · 제21권 제2호Correspondence to editorial on “Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis”Jiaorong Qu, Le Wang, Xiaojiaoyang Li대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”Sisi Yang, Zhenxuan Mapp. 4-6Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12